Literature DB >> 1349053

Sensitivity of serological assays to identify blood donors with hepatitis C viraemia.

M Sugitani1, G Inchauspé, M Shindo, A M Prince.   

Abstract

Blood donors at high risk of hepatitis C virus (HCV) infection were tested for viraemia by the polymerase chain reaction (PCR). PCR results were accepted as positive only if reactive in 3 of 4 tests and if confirmed in an independent laboratory. The sera were also tested by 6 different assays to determine the ability of current serological assays to detect viraemic blood donors. Of 19 PCR-positive sera, only 13 (68%) were detected by the most sensitive of the serological assays. If these results are confirmed, automated PCR assays may be required for blood-donor screening to prevent transmission of HCV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349053     DOI: 10.1016/0140-6736(92)90538-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.

Authors:  C Colin; P Vergnon; A M Jullien; S Excoffier; Y Matillon; C Trepo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

2.  Clinician's guide to diagnostic tests for hepatitis C virus infections.

Authors:  G Delage
Journal:  Can J Infect Dis       Date:  1993-05

3.  Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.

Authors:  D Lavanchy; C Mayerat; B Morel; P Schneider; C Zufferey; J J Gonvers; A Pécoud; P C Frei
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

Review 4.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

5.  Relationship between erythema of the proximal nailfold in HIV-infected patients and hepatitis C virus infection.

Authors:  S Courvoisier; H Grob; M Weisser; P H Itin; M Battegay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

6.  Fluctuating antibody response in a cohort of hepatitis C patients.

Authors:  Said H S Al Dhahry; Shahina Daar; Jameel C Nograles; Situsekara M W W B Rajapakse; Fadhila S S Al Toqi; Geraldine Z Kaminski
Journal:  J Sci Res Med Sci       Date:  2002-04

7.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA.

Authors:  J T Stapleton; D Klinzman; W N Schmidt; M A Pfaller; P Wu; D R LaBrecque; J q Han; M J Phillips; R Woolson; B Alden
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.

Authors:  R Nagayama; F Tsuda; H Okamoto; Y Wang; T Mitsui; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Hyon-Suk Kim
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.